AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2025
Nov 7, 2025
34519_dirs_2025-11-07_62bf86d7-9c08-4888-b1b5-79802753d234.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2025-10-29
Reporting Person: te Boekhorst Paul Francis Olivier (Director, President and CEO)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non Qualified Stock Option (right to buy) | $5.9000 | 2035-09-16 | Common Stock (25327) | Direct | |
| Non Qualified Stock Option (right to buy) | $5.9000 | 2035-09-16 | Common Stock (25327) | Direct | |
| Non Qualified Stock Option (right to buy) | $5.9000 | 2035-09-16 | Common Stock (25329) | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23